Rasagilin NOBEL
Rasagilin NOBEL is a generic from NOBEL Pharma Schweiz AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 79.05 to CHF 194.70 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- NOBEL Pharma Schweiz AG
- ATC code
- N04BD02
- IT group
- 01.08 Parkinson
- Active substances
- Rasagilinum
- Preparation type
- Generic
- On the SL since
- 01/04/2021
- Last price change
- 01/07/2021
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Tabl 1 mg | Blist 30 Stk | CHF 57.60 | CHF 79.05 | 01/04/2021 | B | 7680677110016 |
| Tabl 1 mg | Blist 100 Stk | CHF 163.93 | CHF 194.70 | 01/04/2021 | B | 7680677110023 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Rasagilin NOBEL covered by Swiss health insurance?
Yes. Rasagilin NOBEL is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Rasagilin NOBEL cost in Switzerland?
The public price is the maximum price set by the FOPH and for Rasagilin NOBEL ranges from CHF 79.05 to CHF 194.70 per pack. The ex-factory price ranges from CHF 57.60 to CHF 163.93. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages